Literature DB >> 1117976

Erythropoiesis and erythropoietin in hypo- and hyperthyroidism.

K C Das, M Mukherjee, T K Sarkar, R J Dash, G K Rastogi.   

Abstract

Qualitative and quantitative studies of erythropoiesis in 23 patients with hypothyroidism and 21 patients with hyperthryoidism included routine hematologic evaluation, bone marrow morphology, status of serum iron, B12 and folate red blood cell mass and plasma volume by radioisotope methods, erythrokinetics and radiobioassay of plasma erythropoietin. A majority of patients with the hypothyroid state had significant reduction in red blood cell mas per kg of body weight. The presence of anemia in many of these patients was not evident from hemoglobin and hematocrit values due to concomitant reduction of plasma volume. The erythrokinetic data in hypothyroid patients provided evidence of significant decline of the erythropoietic activity of the bone marrow. Erythroid cells in the marrow were depleted and also showed reduced proliferative activity as indicated by lower 3H-thymidine labeling index. Plasma erythropoietin levels were reduced, often being immeasurable by the polycythemic mouse bioassay technique. These changes in erythropoiesis in the hypothyroid state appear to be a part of physiological adjustment to the reduced oxygen requirement of the tissues due to diminished basal metabolic rate. Similar investigations revealed mild erythrocytosis in a significant proportion of patients with hyperthyroidism. Failure of erythrocytosis to occur in other patients of this group was associated with impaired erythropoiesis due to a deficiency of hemopoietic nutrients such as iron, vitamin B12 and folate. The mean plasma erythropoietin level of these patients was significantly elevated; in 4 patients the levels were in the upper normal range whereas in the rest, the values were above the normal range. The bone marrow showed erythyroid hyperplasia in all patients with hyperthyroidism. The mean 3H-thymidine labeling index of the erythroblasts was also significantly higher than normal in hyperthyroidism; in 8 patients the index was within the normal range whereas in the remaining 13 it was above the normal range. Erythrokinetic studies also provided evidences of increased erythropoietic activity in the bone marrow. It is postulated that thyroid hormones stimulate erythropoiesis, sometimes leading to erythrocytosis provided there is no deficiency of hemopoietic nutrients. Stimulation of erythropoiesis by thryoid hormones appears to be mediated through erythropoietin.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1117976     DOI: 10.1210/jcem-40-2-211

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  30 in total

1.  Haematology research in India: past, present and future.

Authors:  Kanjaksha Ghosh
Journal:  Indian J Hematol Blood Transfus       Date:  2011-05-08       Impact factor: 0.900

2.  Hypopituitarism and anemia: effect of replacement therapy with hydrocortisone and/or levothyroxine.

Authors:  H Nishioka; J Haraoka
Journal:  J Endocrinol Invest       Date:  2005-06       Impact factor: 4.256

Review 3.  The haematology of hyperthyroidism: abnormalities of erythrocytes, leucocytes, thrombocytes and haemostasis.

Authors:  H C Ford; J M Carter
Journal:  Postgrad Med J       Date:  1988-10       Impact factor: 2.401

4.  The Relation Between Thyroid Function and Anemia: A Pooled Analysis of Individual Participant Data.

Authors:  Daisy M Wopereis; Robert S Du Puy; Diana van Heemst; John P Walsh; Alexandra Bremner; Stephan J L Bakker; Douglas C Bauer; Anne R Cappola; Graziano Ceresini; Jean Degryse; Robin P F Dullaart; Martin Feller; Luigi Ferrucci; Carmen Floriani; Oscar H Franco; Massimo Iacoviello; Georgio Iervasi; Misa Imaizumi; J Wouter Jukema; Kay-Tee Khaw; Robert N Luben; Sabrina Molinaro; Matthias Nauck; Kushang V Patel; Robin P Peeters; Bruce M Psaty; Salman Razvi; Roger K Schindhelm; Natasja M van Schoor; David J Stott; Bert Vaes; Mark P J Vanderpump; Henry Völzke; Rudi G J Westendorp; Nicolas Rodondi; Christa M Cobbaert; Jacobijn Gussekloo; Wendy P J den Elzen
Journal:  J Clin Endocrinol Metab       Date:  2018-10-01       Impact factor: 5.958

5.  Triiodothyronine suppresses activin-induced differentiation of erythroleukemia K562 cells under hypoxic conditions.

Authors:  Yoritsuna Yamamoto; Mieno Shiraishi; Masanori Fujita; Itaru Kojima; Yuji Tanaka; Shoichi Tachibana
Journal:  Mol Cell Biochem       Date:  2014-03-07       Impact factor: 3.396

6.  Graves' disease mimicking beta-thalassemia trait.

Authors:  M S Akasheh
Journal:  Postgrad Med J       Date:  1994-04       Impact factor: 2.401

7.  Elevation of HbA1C in Non-diabetic Hypothyroid Individuals: Is Anaemia the Connecting Link? -A Preliminary Study.

Authors:  Alap L Christy; Poornima Manjrekar; Ruby P Babu; Rukmini M S; Anupama Hegde
Journal:  J Clin Diagn Res       Date:  2013-10-29

8.  Oxazepam pharmacokinetics in thyroid disease.

Authors:  A K Scott; A S Khir; P D Bewsher; G M Hawksworth
Journal:  Br J Clin Pharmacol       Date:  1984-01       Impact factor: 4.335

9.  The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.

Authors:  A Bauer; W Mikulits; G Lagger; G Stengl; G Brosch; H Beug
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

Review 10.  Pain and thyroid hormones.

Authors:  Anna Maria Aloisi; Stella Vodo; Michelangelo Buonocore
Journal:  Neurol Sci       Date:  2013-04-23       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.